Low neutralisation of the omicron BA.2 sublineage in boosted individuals who had breakthrough infections.

Karaba, Andrew H; Johnston, Trevor S; Aytenfisu, Tihitina Y; Woldemeskel, Bezawit A; Garliss, Caroline C; Cox, Andrea L; Blankson, Joel N

Karaba, Andrew H; Johnston, Trevor S; Aytenfisu, Tihitina Y; Woldemeskel, Bezawit A; Garliss, Caroline C; Cox, Andrea L; Blankson, Joel N.

Afiliación

Karaba AH; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Johnston TS; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Aytenfisu TY; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Woldemeskel BA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Garliss CC; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Cox AL; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Blankson JN; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Electronic address: jblanks@jhmi.edu.

Lancet Microbe ; 3(9): e644, 2022 09.

Article en En | MEDLINE | ID: mdl-35752198

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Lancet Microbe Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google